The epidermal growth factor receptor (EGFR) and vascular endothelial growth factor receptor (VEGFR-2), as potent targets for cancer therapy, have been proved to be crucial in signal transduction pathways involved in tumor cell proliferation, differentiation, migration and angiogenesis [1,2,3,4]. The gene discussed is KDR; the disease is cancer.